期刊文献+

河南汉族缺血性脑血管病患者胱硫醚β-合成酶基因T27796C多态性检测

Distribution of cystathionine β-synthase gene T27796C polymorphism in Henan Han population with ischemic cerebrovascular diseases
下载PDF
导出
摘要 目的:探讨胱硫醚β-合成酶(CBS)基因T27796C多态性与河南汉族人群缺血性脑血管病的关系。方法:运用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法对92例缺血性脑血管病患者(包括血栓性脑梗死、腔隙性脑梗死和短暂性脑缺血发作)及52例对照进行CBS基因T27796C多态性检测。结果:病例组CBS基因T27796CT/T、C/T和C/C基因型频率分别为29.3%、57.6%和13.0%,T和C等位基因频率分别为58.2%和41.8%,对照组T/T、C/T和C/C基因型频率分别为13.5%、61.5%和25.0%,T和C等位基因频率分别为44.2%和55.8%。2组CBS基因T27796CC/C基因型频率相比,差异有统计学意义(χ2=6.344,P=0.012);C等位基因频率相比,差异也有统计学意义(χ2=5.171,P=0.023)。结论:CBS基因T27796C突变可能与缺血性脑血管病有关。 Aim:To explore the relationship between cystathionine β-synthase(CBS) gene T27796C polymorphism and ischemic cerebrovascular diseases in Henan Han population.Methods:CBS gene T27796C polymorphism in 92 patients with ischemic cerebrovascular disease and 52 controls were detected using PCR-RFLP.Results:In patient group,the frequencies of CBS gene T27796C T/T,C/T and C/C genotypes were 29.3%,57.6% and 13.0%,and T and C allele frequencies were 58.2% and 41.8%,while in the control group,the frequencies of CBS gene T27796C T/T,C/T and C/C genotypes were 13.5%,61.5% and 25.0%,and T and C allele frequencies were 44.2% and 55.8%. There were significant differences in the frequencies of genotypes between the two groups (χ2=6.344,P=0.012),and there were significant difference in the frequencies of C alleles genotypes between the two groups (χ2=5.171,P=0.023).Conclusion:There may be a relationship between CBS gene T27796C mutation and ischemic cerebrovascular diseases.
作者 路燕 滕军放
出处 《郑州大学学报(医学版)》 CAS 北大核心 2010年第3期416-419,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省医学科技攻关基金资助项目2009041
关键词 缺血性脑血管病 胱硫醚Β-合成酶 基因多态性 河南 汉族 ischemic cerebrovascular disease cystathionine β-synthase gene polymorphism Henan province Han population
  • 相关文献

参考文献4

二级参考文献64

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33024
  • 2[1]Coull B M, Malinow M R, Beamer N, Sexton G, Nordt F, de Garmo P. Elevated plasma homocysteine concentration as a possible independent risk factor for stroke. Stroke, 1990, 21:572.
  • 3[2]Houston P E, Rana S, Sekhsaria S, Perlin E, Kim S, Castrol O L. Homocysteine in sickle cell disease: Relationship to stroke. AmJ Med, 1997, 103: 192~196.
  • 4[3]Ueland P M, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma level in health, disease, and therapy. JLabClin Med, 1989, 114: 473~501.
  • 5[4]Frosst P, Blam H J, Milos R, Goyette P, Sheppard C A,Mattews R G, Boers G J, den Heijer M, Kluijtmans LA. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet,1995, 10: 111~113.
  • 6[5]Tsia M Y, Gary U, Key N S. Molecular and biochemical ap proaches in the identification of heterozgotes for homocysteinuria. Atherosclerosis, 1996, 122: 69~77.
  • 7[6]Franco R F, Araujo A G, Guerreiro J F, Elion J, Zago M A.Analysis of the 677C→T mutation of the methylenetetrahydro folate reductase gene in different ethnic groups. Thromb Hae most, 1998, 79(1): 119~121.
  • 8[8]Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C,Kurihara Y, Shindo T, Oh-hashi Y, Kitamura K, Yazaki Y.Methylenetetrahydrofolate Reductase Gene Polymorphism and Ischemic Stroke in Japanese. Arterioscler Thromb Vasc Biol,1998, 18: 1465~1469.
  • 9[9]Harmon D L, Doyle R M, Meleady R, Doyle M, Shields D C,Barry R, Coakley D, Graham I M, Whitehead A S. Genetic Analysis of the Thermolabile Variant of 5., 10-Methylenetetrahydrofolate Reductase as a Risk Factor for Ischemic Stroke.Arterioscler Thromb Vasc Biol, 1999, 99: 208~211.
  • 10[10]Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A,Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H. A Common mutation A1298C in human methylenetetrahydrofolate reductase (MTHFR) association with plasma total homocysteine and folate concentrations. J Nutr, 1999, 129 (9):1656~1661.

共引文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部